108 related articles for article (PubMed ID: 17569132)
1. Genotype phenotype classification of hepatocellular adenoma.
Bioulac-Sage P; Blanc JF; Rebouissou S; Balabaud C; Zucman-Rossi J
World J Gastroenterol; 2007 May; 13(19):2649-54. PubMed ID: 17569132
[TBL] [Abstract][Full Text] [Related]
2. Focal nodular hyperplasia-like nodules arising in the setting of hepatic vascular disorders with portosystemic shunting show β-catenin activation.
Umetsu SE; Joseph NM; Cho SJ; Morotti R; Deshpande V; Jain D; Kakar S
Hum Pathol; 2023 Dec; 142():20-26. PubMed ID: 37806391
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular Adenoma: Report of 2 Cases That Highlight the Relevance of Phenotype-Genotype Correlation in the Pediatric Population.
Jiao J; Finberg KE; Jain D; Morotti R
Pediatr Dev Pathol; 2023; 26(4):394-403. PubMed ID: 37334553
[TBL] [Abstract][Full Text] [Related]
4. Hepatic adenoma: evolution of a more individualized treatment approach.
Aziz H; Underwood PW; Gosse MD; Afyouni S; Kamel I; Pawlik TM
J Gastrointest Surg; 2024 Jun; 28(6):975-982. PubMed ID: 38521190
[TBL] [Abstract][Full Text] [Related]
5. Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification.
Balabaud C; Al-Rabih WR; Chen PJ; Evason K; Ferrell L; Hernandez-Prera JC; Huang SF; Longerich T; Park YN; Quaglia A; Schirmacher P; Sempoux C; Thung SN; Torbenson M; Wee A; Yeh MM; Yeh SH; Le Bail B; Zucman-Rossi J; Bioulac-Sage P
Int J Hepatol; 2013; 2013():268625. PubMed ID: 23691331
[TBL] [Abstract][Full Text] [Related]
6. Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics.
Dhingra S; Fiel MI
Arch Pathol Lab Med; 2014 Aug; 138(8):1090-7. PubMed ID: 25076298
[TBL] [Abstract][Full Text] [Related]
7. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular Adenoma and Focal Nodular Hyperplasia.
Mounajjed T
Clin Liver Dis (Hoboken); 2021 Apr; 17(4):244-248. PubMed ID: 33968383
[No Abstract] [Full Text] [Related]
9. HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI.
Auer TA; Walter-Rittel T; Geisel D; Schöning W; Schmelzle M; Müller T; Sinn B; Denecke T; Hamm B; Fehrenbach U
BMC Med Imaging; 2021 Feb; 21(1):28. PubMed ID: 33588783
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for the Treatment of Hepatocellular Adenoma in the Era of Molecular Biology: An Experience-Based Surgeons' Perspective.
Herman P; Fonseca GM; Kruger JAP; Jeismann VB; Coelho FF
J Gastrointest Surg; 2021 Jun; 25(6):1494-1502. PubMed ID: 32666496
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
Auer TA; Fehrenbach U; Grieser C; Penzkofer T; Geisel D; Schmelzle M; Müller T; Bläker H; Seehofer D; Denecke T
Eur Radiol; 2020 Jun; 30(6):3497-3506. PubMed ID: 32086574
[TBL] [Abstract][Full Text] [Related]
12. Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma.
Hale G; Liu X; Hu J; Xu Z; Che L; Solomon D; Tsokos C; Shafizadeh N; Chen X; Gill R; Kakar S
Mod Pathol; 2016 Nov; 29(11):1370-1380. PubMed ID: 27469330
[TBL] [Abstract][Full Text] [Related]
13. Histopathological characteristics of glutamine synthetase-positive hepatic tumor lesions in a mouse model of spontaneous metabolic syndrome (TSOD mouse).
Takahashi T; Nishida T; Baba H; Hatta H; Imura J; Sutoh M; Toyohara S; Hokao R; Watanabe S; Ogawa H; Uehara H; Tsuneyama K
Mol Clin Oncol; 2016 Aug; 5(2):267-270. PubMed ID: 27446562
[TBL] [Abstract][Full Text] [Related]
14. Benign liver lesions: grey-scale and contrast-enhanced ultrasound appearances.
Obaro AE; Ryan SM
Ultrasound; 2015 May; 23(2):116-25. PubMed ID: 27433246
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?
Park YS; Lee CH; Kim JW; Shin S; Park CM
World J Gastroenterol; 2016 Jan; 22(1):284-99. PubMed ID: 26755877
[TBL] [Abstract][Full Text] [Related]
16. Pigmented hepatocellular adenomas have a high risk of atypia and malignancy.
Mounajjed T; Yasir S; Aleff PA; Torbenson MS
Mod Pathol; 2015 Sep; 28(9):1265-74. PubMed ID: 26205181
[TBL] [Abstract][Full Text] [Related]
17. Multiple hepatocellular adenomas presenting in a male 8 years post-pancreaticoduodenectomy for islet cell tumor of the pancreas.
Gallagher TK; Venkatesh UK; Maguire DM
J Nat Sci Biol Med; 2015; 6(1):239-41. PubMed ID: 25810673
[TBL] [Abstract][Full Text] [Related]
18. Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma.
Khanna M; Ramanathan S; Fasih N; Schieda N; Virmani V; McInnes MD
Insights Imaging; 2015 Jun; 6(3):347-62. PubMed ID: 25790815
[TBL] [Abstract][Full Text] [Related]
19. Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience.
Grieser C; Steffen IG; Kramme IB; Bläker H; Kilic E; Perez Fernandez CM; Seehofer D; Schott E; Hamm B; Denecke T
Eur Radiol; 2014 Jun; 24(6):1339-48. PubMed ID: 24658870
[TBL] [Abstract][Full Text] [Related]
20. Genotype-phenotype correlations in hepatocellular adenoma: an update of MRI findings.
Thomeer MG; E Bröker ME; de Lussanet Q; Biermann K; Dwarkasing RS; de Man R; Ijzermans JN; de Vries M
Diagn Interv Radiol; 2014; 20(3):193-9. PubMed ID: 24509184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
